217 related articles for article (PubMed ID: 4172727)
1. Fibrinolysis.
Sherry S
Annu Rev Med; 1968; 19():247-68. PubMed ID: 4172727
[No Abstract] [Full Text] [Related]
2. [The thrombolytic medications].
Rignault D
Presse Med (1893); 1969 Jan; 77(2):55-8. PubMed ID: 4239477
[No Abstract] [Full Text] [Related]
3. Concepts of clot lysis.
Francis CW; Marder VJ
Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis.
Sharp AA; Allington MJ; Chesterman CN
J Clin Pathol; 1972 Jul; 25(7):630-1. PubMed ID: 4115998
[No Abstract] [Full Text] [Related]
5. [Fibrinolysis and thrombolytic therapy under laboratory control].
Osten W
Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
[No Abstract] [Full Text] [Related]
6. [Thrombolytic treatment of thromboembolytic conditions].
Gormsen J
Ugeskr Laeger; 1966 Oct; 128(42):1235-45. PubMed ID: 4231392
[No Abstract] [Full Text] [Related]
7. Effect of fibrinolysis on adhesion and aggregation of human platelets.
Cronberg S
Thromb Diath Haemorrh; 1968 Jul; 19(3):474-82. PubMed ID: 4236822
[No Abstract] [Full Text] [Related]
8. The fibrinolytic system and its pharmacologic activation for thrombolysis.
Sherry S
Cardiol Clin; 1987 Feb; 5(1):1-11. PubMed ID: 2951008
[TBL] [Abstract][Full Text] [Related]
9. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
Kwaan HC
Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
[No Abstract] [Full Text] [Related]
10. Fibrinolytic agents.
Sherry S
Dis Mon; 1969 May; ():3-32. PubMed ID: 4241828
[No Abstract] [Full Text] [Related]
11. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
Fischer M
Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
[No Abstract] [Full Text] [Related]
12. Perspectives: fibrinolysis and thrombolysis.
Sherry S
Thromb Diath Haemorrh Suppl; 1966; 20():1-12. PubMed ID: 5973051
[No Abstract] [Full Text] [Related]
13. Fibrinolytic therapy.
Gallus AS
Compr Ther; 1976 Apr; 2(4):67-73. PubMed ID: 131019
[No Abstract] [Full Text] [Related]
14. [Position and developmental trends in fibrinolytic therapy].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
[TBL] [Abstract][Full Text] [Related]
15. [Current situation and developmental trends in the field of thrombolytic agents].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):5-8. PubMed ID: 4134480
[No Abstract] [Full Text] [Related]
16. The hematologic consequences of thrombolytic therapy.
Fletcher AP; Alkjaersig NK
Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
[No Abstract] [Full Text] [Related]
17. [Contemporary data on the human fibrinolytic system].
Andreenko GV
Klin Med (Mosk); 1970 Oct; 48(10):16-24. PubMed ID: 4252327
[No Abstract] [Full Text] [Related]
18. Fibrinolysis: molecular mechanism and pathophysiological aspects.
Lijnen HR
Sangre (Barc); 1984; 29(4-C):755-61. PubMed ID: 6240123
[No Abstract] [Full Text] [Related]
19. [Long-lasting activation of the fibrinolytic system in blood and its clinical application].
Bielawiec M
Pol Tyg Lek; 1969 Jan; 24(2):63-6. PubMed ID: 4240415
[No Abstract] [Full Text] [Related]
20. Thrombolysis.
Sharp AA
Adv Cardiol; 1970; 4():225-32. PubMed ID: 4250170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
